What Is The Predicted Revenue Outlook For The Global Lung Cancer Diagnostic And Screening Market To Surpass $3.68 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Lung Cancer Diagnostic And Screening Market?
The market size of lung cancer diagnosis and screening has significantly expanded in the recent past. Its growth is expected to continue from a value of $2.34 billion in 2024 to $2.56 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The precedent growth in this sector can be attributed to the advancement in digital imaging, standardization of screening procedures, public health movements against tobacco usage, creation of cancer registries, and improvements in the field of pathology analysis.
Anticipated to witness robust expansion in the approaching years, the lung cancer diagnostic and screening market is projected to reach a valuation of $3.68 billion by 2029. This growth, reflecting a compound annual growth rate (CAGR) of 9.5%, is attributed to several factors such as increased instances of lung cancer, heightened focus on early detection, the broadening of high-risk screening regimes, a shift towards personalized medicine, and strong governmental initiatives and funding. Throughout this forecast period, key trends are expected to emerge, including the development of new screening methods, advancements in biomarker testing, artificial intelligence (AI) integration, a rise in the adoption of liquid biopsies, increased attention on early stage detection, and the continued growth of low-dose CT screening programs.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12043&type=smp
Which Industry Forces Are Driving The Lung Cancer Diagnostic And Screening Market Forward?
The rise in lung cancer cases is anticipated to stimulate the lung cancer diagnostic and screening market’s growth. Characterized by the uncontrolled growth of abnormal cells in lung tissues, lung cancer is a deadly disease, its symptoms including coughing, chest pain, and difficulty in breathing. Early diagnosis of this disease is facilitated by lung cancer diagnosis and screening, utilizing various tests such as an incisional biopsy and bronchoscopy. As reported by the American Cancer Society, a US government organization, in January 2023, the United States saw approximately 238,340 new lung cancer cases (117,550 in men and 120,790 in women) and around 127,070 deaths due to lung cancer (67,160 in men and 59,910 in women). Consequently, the growing prevalence of lung cancer is fueling the expansion of the lung cancer diagnostic and screening market.
How Is The Lung Cancer Diagnostic And Screening Market Organized By Different Segments?
The lung cancer diagnostic and screeningmarket covered in this report is segmented –
1) By Product: Instruments; Consumables And Accessories
2) By Test: Biomarkers Tests; Imaging Test; Biopsy; Blood Test; Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer; Small Cell Lung Cancer
4) By End User: Hospital; Independent Diagnostic Laboratories; Diagnostic Imaging Centers; Cancer Research Institutes; Other End-Users
Subsegments:
1) By Instruments: Imaging Devices; Biopsy Devices; Bronchoscopy Systems
2) By Consumables And Accessories: Biopsy Needles; Reagents And Assays; Imaging Contrast Agents; Patient Preparation Equipment; Sample Collection Kits; Laboratory Supplies
What Key Trends Are Driving Growth In The Lung Cancer Diagnostic And Screening Market?
Leading businesses in the lung cancer diagnostic and screening sector are innovating technologies like lung cancer examinations to amplify early detection, enrich diagnostic precision, and enable tailored treatment strategies for patients with a high possibility of contracting the disease. These tests are procedures planned to identify the existence of lung cancer using diverse techniques such as imaging, biomarker analysis, and cytological studies. For example, Freenome, a biotechnology firm based in the US, unveiled the PROACT LUNG in December 2023. The introduction of this trial marks a significant move towards transforming lung cancer screenings, with the potential to lead to earlier diagnoses and improved patient results while covering the present gaps in screening procedures.
Who Are The Primary Market Leaders In The Lung Cancer Diagnostic And Screening Market?
Major companies operating in the lung cancer diagnostic and screening market include Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, OncimmuneHoldings Plc, Broncus Medical Inc., OncoCyte, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix,
Access The Complete Report Here:
How Do Regional Dynamics Influence The Lung Cancer Diagnostic And Screening Market Performance?
North America was the largest region in the lung cancer diagnostic and screening market in 2024. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12043&type=smp
Browse Through More Reports Similar to the Global Lung Cancer Diagnostic And Screening Market 2025, By The Business Research Company
Cold Chain Packaging Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-chain-packaging-global-market-report
Pharmaceutical Logistics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report
Chemicals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
